MRS4596
MRS4596 is a potent and selective P2X4 receptor antagonist with an IC50 value of 1.38 μM for human P2X4 receptor. MRS4596 has neuroprotective and neuro-rehabilitative activities in ischemic stroke model. MRS4596 can be used in research of ischemic stroke .
For research use only. We do not sell to patients.
- CAS No.: 2840581-38-4
- Formula: C22H15N4NaO3S
- Molecular Weight:438.43
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All P2X Receptor Isoforms
More
Biological Activity
Description
IC50 & Target
IC50: 1.38 μM (human P2X4 receptor)[1]
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male and female young C57B/6 mice (8-12 weeks; induced transient focal cerebral ischemia by a 60 min right middle cerebral artery occlusion)[1]
-
Dosage:5 mg/kg
-
Administration:3 days continuous infusion with an Alzet minipump
-
Result:Decreased in total hemispheric infarct volume while effects were not significant on cortical or striatal infarct volume alone.
Chemical Information
-
CAS No. 2840581-38-4
-
Molecular Weight 438.43
-
Formula C22H15N4NaO3S
-
SMILES
O=C(C1)NC(C2=CC=C(C=C2C=C3)C)=C3N(C4=CC=CC(C([N-]5)=NOC5=S)=C4)C1=O.[Na+]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)